Clinical consequences of Aspergillus disease in cystic fibrosis

Completed

• Conditions: Pulmonary Aspergillus disease in patients with cystic fibrosis; Respiratory

• Registration Number: ISRCTN16364688
• Lead Sponsor: Wythenshawe Hospital, Manchester Univaersity NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-22
• Last Update Posted: 30 April 2018
• Study Completion: 2018-09-30

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

All patients will have taken part in study REC ref: 07/Q1403/70 between 2008-2011 (number = 129). Surviving patients who have not received a lung transplant or moved away from the unit since that time will be eligible for prospective reclassification of Aspergillus disease. All 129 patients will be followed up for retrospective data.
1. Cystic fibrosis patients > 18 years old, both male and female
2. Patients who have taken part in study REC ref: 07/Q1403/70
3. Patients eligible for reclassification of Aspergillus disease if not undergone lung transplantation or not moved away from area

Exclusion Criteria

1. Non cystic fibrosis patients
2. Patients not involved in study REC reference number 07/Q1403/70
3. Patients who have undergone lung transplantation
4. Patients who have moved away from the area during follow-up time from original study

Study & Design

• Study Type: Observational
• Study Design: Not specified